Bone Biologics Inc (BBLG) Enterprise Value to EBITDA Ratio
Bone Biologics develops advanced bioscaffolds to accelerate skeletal regeneration, restoring functionality to patients following injuries. Business valuation growth is driven by NELL-1 protein trials and interest from pharmaceutical behemoths in the company's patents. Bone Biologics is currently focusing on R&D for spinal surgery. This chart on GURU.Markets reflects a price trend with an EV/EBITDA of 0.00, confirming an active development stage.
Comprehensive metric breakdowns and analytics for bonebiologics.com (BBLG)
- current price and projected stock value:
- market capitalization details:
- business book valuation details:
- debt burden and liquidity indicators:
- financial results and valuation multiples details:
BBLG - Net Financial Result|Projected Future Earnings Bone Biologics|BBLG - Price to Earnings Ratio|Forward P/E Multiple Bone Biologics|BBLG - PEG Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Bone Biologics Inc|BBLG - Profit before payment of interest, taxes and amortization|Net earnings per share for the last 12 months Bone Biologics|BBLG - Earnings per share for the trailing year|Quarterly EPS earnings growth bonebiologics.com|BBLG - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year Bone Biologics
Analysis of all company metrics:Bone Biologics Corporation BBLG
Scaling implant trials through third-party contractors directly impacts the operating margins of Bone Biologics. This indicator compares the total enterprise value with earnings before interest, taxes, depreciation, and amortization, capturing the sensitivity of capitalization to the cost of debt. Analyzing the historical EV/EBITDA multiple of the business allows investors to determine the real value of assets, stripped of tax and debt distortions.
Competitor analysis
EV/EBITDA Multiple BSX (Boston Scientific Inc)|Total Company Value to Operating Income Before Depreciation Ratio Edwards Lifesciences Inc. (EW)|RMD: Enterprise Value to EBITDA Ratio|Company Value to Operating Income Before Depreciation Ratio PODD|ZBH: EV/EBITDA Multiple|Company Value to EBITDA The Cooper Companies, Inc. (COO)|ALGN (Align Technology Inc) - EV/EBITDA Multiple|Enterprise Value to Operating Income Before Depreciation GMED (NuVasive)|Enterprise Value to EBITDA Ratio TMDX (TransMedics)|ATEC (atecspine.com) - Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Artivion AORT|ENOV - Enterprise Value to EBITDA Ratio|Integra - EV/EBITDA Multiple|Company Value to EBITDA Establishment Labs Inc|BBNX: EV/EBITDA Multiple|Enterprise Value to Operating Income Before Depreciation IRMD|EMBC (Embecta) - EV/EBITDA Multiple|Tandem Diabetes Care Inc (TNDM) - Total Company Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple AXGN|Enterprise Value to EBITDA Ratio SI-BONE Medical SIBN|EV/EBITDA Multiple OFIX (Orthofix Medical Inc.)|EV/EBITDA Multiple bioventus.com BVS|KIDS - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|TMCI: Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|SRTA (Strata Critical Medical Corp) - Enterprise Value to EBITDA Ratio|Carlsmed Medical - Business Value to Operating Income Before Depreciation|RXST (RxSight, Inc.) - EV/EBITDA Multiple|Company Value to EBITDA ClearPoint CLPT|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Stereotaxis (STXS)|Neuronetics Inc. (STIM) - Enterprise Value to EBITDA Multiple|Sight Sciences, Inc - Enterprise Value to EBITDA Ratio|EV/EBITDA Multiple orchestrabiomed.com OBIO|Anika - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio inspiremd.com NSPR|zhjmedical.com (ZJYL) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to Operating Income Before Depreciation Ratio VANI (Vivani Medical)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Xtant Medical Holdings, Inc.|Enterprise Value to EBITDA Ratio NeuroOne Medical Technologies Corp. (NMTC)|EV/EBITDA Multiple MODD|MYO - Company Value to EBITDA|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Envoy Medical COCH|VVOS: Enterprise Value to Operating Income Before Depreciation|NVNO: Enterprise Value to EBITDA Ratio|Sintx Technologies - Enterprise Value to Operating Income Before Depreciation Ratio|TNON: EV/EBITDA Multiple|LFWD (rewalk.com) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Autonomix Medical Inc.|Company Value to EBITDA INVO Bioscience IVF|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Axonics Modulation Technologies (AXNX)|Biolase Inc. - Enterprise Value to Operating Income Before Depreciation|EV/EBITDA Multiple DYNT (Dynatronics)|Paragon 28 Inc. (FNA) - Company Value to EBITDA|INVO: Enterprise Value to EBITDA Ratio
